Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-20-008837
Filing Date
2020-04-29
Accepted
2020-04-29 16:27:23
Documents
4
Period of Report
2020-06-17
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dffn20200421_def14a.htm DEF 14A 521836
2 logo.jpg GRAPHIC 22192
3 proxy01.jpg GRAPHIC 172156
4 proxy02.jpg GRAPHIC 131827
  Complete submission text file 0001437749-20-008837.txt   972673
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37942 | Film No.: 20830739
SIC: 2834 Pharmaceutical Preparations